How anti-neutrophil cytoplasmic autoantibodies activate neutrophils
Author:
- 2 August 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 169 (3) , 220-228
Abstract
OTHER ARTICLES PUBLISHED ON ANCA IN THIS ISSUE Animal models of anti‐neutrophil cytoplasmic antibody‐associated vasculitis. Clinical and Experimental Immunology 2012, 169: 229–37. Neutrophils are pivotal to host defence during infectious diseases. However, activated neutrophils may also cause undesired tissue damage. Ample examples include small‐vessel inflammatory diseases (vasculitis) that are associated with anti‐neutrophil cytoplasmic autoantibodies (ANCA) residing in the patients' plasma. In addition to being an important diagnostic tool, convincing evidence shows that ANCA are pathogenic. ANCA–neutrophil interactions induce important cellular responses that result in highly inflammatory necrotizing vascular damage. The interaction begins with ANCA binding to their target antigens on primed neutrophils, proceeds by recruiting transmembrane molecules to initiate intracellular signal transduction and culminates in activation of effector functions that ultimately mediate the tissue damage.Keywords
This publication has 83 references indexed in Scilit:
- Anti–LAMP-2 Antibodies Are Not Prevalent in Patients With Antineutrophil Cytoplasmic Autoantibody GlomerulonephritisJournal of the American Society of Nephrology, 2012
- Neutrophil Serine Proteases Promote IL-1β Generation and Injury in Necrotizing Crescentic GlomerulonephritisJournal of the American Society of Nephrology, 2012
- IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitisProceedings of the National Academy of Sciences, 2011
- Immunoglobulin subclass determines ability of immunoglobulin (Ig)G to capture and activate neutrophils presented as normal human IgG or disease-associated anti-neutrophil cytoplasm antibody (ANCA)-IgGClinical and Experimental Immunology, 2011
- Complement Receptor Mac-1 Is an Adaptor for NB1 (CD177)-mediated PR3-ANCA Neutrophil ActivationJournal of Biological Chemistry, 2011
- Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitisJournal of Clinical Investigation, 2010
- The use of small molecule high-throughput screening to identify inhibitors of the proteinase 3-NB1 interactionClinical and Experimental Immunology, 2010
- Netting neutrophils in autoimmune small-vessel vasculitisNature Medicine, 2009
- Molecular mimicry in pauci-immune focal necrotizing glomerulonephritisNature Medicine, 2008
- Neutrophil surface presentation of the anti-neutrophil cytoplasmic antibody-antigen proteinase 3 depends on N-terminal processingClinical and Experimental Immunology, 2008